Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives Mario CazzolaPaola RoglianiMaria Gabriella Matera Current Opinion 28 August 2015 Pages: 1575 - 1585
New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins Margaret V. Ragni Leading Article 27 August 2015 Pages: 1587 - 1600
Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics Sophie MarchalAmélie El HorLina Bezdetnaya Review Article 01 September 2015 Pages: 1601 - 1611
Current Strategies to Reduce Gastrointestinal Bleeding Risk Associated with Antiplatelet Agents Parth J. ParekhEdward C. Oldfield IVDavid A. Johnson Review Article 02 September 2015 Pages: 1613 - 1625
Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities Paul P. DobeshJohn Fanikos Review Article Open access 14 September 2015 Pages: 1627 - 1644
Roflumilast: A Review in COPD Karly P. Garnock-Jones Adis Drug Evaluation 04 September 2015 Pages: 1645 - 1656
Perampanel: A Review in Drug-Resistant Epilepsy James E. Frampton Adis Drug Evaluation 14 September 2015 Pages: 1657 - 1668
Eliglustat: A Review in Gaucher Disease Type 1 Lesley J. Scott Adis Drug Evaluation 18 September 2015 Pages: 1669 - 1678
AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus Esther S. KimGreg L. Plosker Adis Drug Evaluation 18 September 2015 Pages: 1679 - 1686
Brexpiprazole: First Global Approval Sarah L. Greig AdisInsight Report 27 August 2015 Pages: 1687 - 1697
Alirocumab: First Global Approval Anthony Markham AdisInsight Report 14 September 2015 Pages: 1699 - 1705
